abi-1179
·Code: 1179
abi-1179: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | Phase 1 |
Clinical Trials (1)
A Phase 1a/1b, Blinded, Placebo-Controlled Study of the Safety, Tolerability and Pharmacokinetics of Single- and Multiple Ascending Doses of ABI-1179 in Healthy Subjects and in Subjects Who Are Seropositive for Herpes Simplex Virus Type 2 With Recurrent Genital Herpes
Frequently asked questions
Who is developing abi-1179?
abi-1179 is being developed by ASSEMBLY BIOSCIENCES, INC..
How many clinical trials involve abi-1179?
BioSniper tracks 1 clinical trial involving abi-1179.
Get deeper analysis on abi-1179
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis